I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response Donika PlykuRobert F. HobbsDouglas Van Nostrand Original Article 04 February 2022 Pages: 213 - 223
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab Florian EudeFlorian GuisierPierre Decazes Original Article 21 January 2022 Pages: 224 - 234
Feasibility of 125I-RGD uptake as a marker of angiogenesis after myocardial infarction Takafumi YamaseJunichi TakiSeigo Kinuya Original Article 26 November 2021 Pages: 235 - 243
Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting Motoko MorishimaTomonari KiriyamaYosuke Ishii Original Article Open access 25 November 2021 Pages: 244 - 254
Correction to: Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting Motoko MorishimaTomonari KiriyamaYosuke Ishii Correction Open access 13 December 2021 Pages: 255 - 255
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma Kun-Han LueSung-Chao ChuShu-Hsin Liu Original Article 24 November 2021 Pages: 256 - 266
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma Anri InakiTohru ShigaSeigo Kinuya Original Article Open access 06 December 2021 Pages: 267 - 278
Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test Yoshiaki MiyazakiMasashi KameyamaNobuyuki Tabata Original Article Open access 01 January 2022 Pages: 279 - 284
A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients Miwako TakahashiShuntaro YoshimuraTaiga Yamaya Original Article Open access 29 November 2021 Pages: 285 - 292
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging Katharina KesselRobert SeifertKambiz Rahbar Original Article Open access 02 December 2021 Pages: 293 - 301
Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study Tomoaki OtaniTsuneo SagaYuji Nakamoto Original Article 22 January 2022 Pages: 302 - 309
Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses Ayşegül AksuÖzge Vural TopuzBurçak Yılmaz Original Article 06 January 2022 Pages: 310 - 318
Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo Yoichi ShimizuSho KoyasuYuji Nakamoto Short Communication 16 January 2022 Pages: 319 - 326
Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy Wajana Thaweerat Letter to the Editor 30 January 2022 Pages: 327 - 328
